Trabeculoplasty may benefit patients of glaucoma and ocular surface disease: study
Finland: Trabeculectomy and the resulting cessation of topical glaucoma medication are very beneficial to the ocular surface as indicated by clinical signs and tear proteomics, finds a recent study in the journal Acta Ophthalmologica. Further, throughout the 1‐year follow‐up, the state of conjunctiva improved while there was an increase in the lipid transport‐associated functions and a decrease in the levels of pro‐inflammatory proteins.
Anu Vaajanen, Tays Eye Centre, Tampere University Hospital, Tampere, Finland, and colleagues reported changes in the ocular surface and tear proteomics after discontinuation of chronic glaucoma medication.
The researchers recruited patients who required trabeculectomy from the glaucoma clinic of Tampere University Hospital, Finland. The report included fifty‐seven patients with the previous history of anti‐glaucomatous eye drops (8.1 ± 6.8 years) and underwent a successful trabeculectomy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.